[1] LIU K,GOLDSTEIN S,VIJAYAN A,et al.AKI!Now initiative:recommendations for awareness,recognition,and management of AKI[J].Clin J Am Soc Nephrol,2020,15(12):1838-1847.
[2] ETIENNE M,JORGE C,SANGEETA H,et al.Recognition and management of acute kidney injury in children:the ISN 0by25 Global Snapshot study[J].PLoS One,2018,13(5):e0196586.
[3] KHWAJA A.KDIGO clinical practice guidelines for acute kidney injury[J].Nephron Clin Pract,2012,120(4):c179-c184.
[4] PARAGAS N,QIU A,ZHANG Q,et al.The Ngal reporter mouse detects the response of the kidney to injury in real time[J].Nat Med,2011,17(2):216-222.
[5] PARAGAS N,KULKARNI R,WERTH M,et al.α-intercalated cells defend the urinary system from bacterial infection[J].J Clin Invest,2014,124(7):2963-2976.
[6] SANCHO-MARTÍNEZ S M,BLANCO-GOZALO V,QUIROS Y,et al.Impaired tubular reabsorption is the main mechanism explaining increases in urinary NGAL excretion following acute kidney injury in rats[J].Toxicol Sci,2020,175(1):75-86.
[7] WOYNIEC W,RATKOWSKI W,RENKE J,et al.Changes in novel AKI biomarkers after exercise.A systematic review[J].Int J Mol Sci,2020,21(16):5673.
[8] KASHANI K,CHEUNGPASITPORN W,RONCO C.Biomarkers of acute kidney injury:the pathway from discovery to clinical adoption[J].Clin Chem Lab Med,2017,55(8):1074-1089.
[9] AU V,FEIT J,BARASCH J,et al.Urinary neutrophil gelatinase-associated lipocalin(NGAL) distinguishes sustained from transient acute kidney injury after general surgery[J].Kidney Int Rep,2016,1(1):3-9.
[10] HAN W,BAILLY V,ABICHANDANI R,et al.Kidney injury molecule-1(KIM-1):a novel biomarker for human renal proximal tubule injury[J].Kidney Int,2002,62(1):237-244.
[11] KHREBA N A,ABDELSALAM M,WAHAB A M,et al.Kidney injury molecule 1(KIM-1) as an early predictor for acute kidney injury in post-cardiopulmonary bypass(CPB) in open heart surgery patients[J].Int J Nephrol,2019,2019:1-6.
[12] MORI Y,AJAY A,CHANG J,et al.KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease[J].Cell Metabolism,2021,33(5):1042-1061.e7.
[13] XIE Y,WANG Q,WANG C,et al.High urinary excretion of kidney injury molecule-1 predicts adverse outcomes in acute kidney injury:a case control study[J].Critical Care(London,England),2016,20:286.
[14] SHAO X,TIAN L,XU W,et al.Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury:a meta-analysis[J].PLoS One,2014,9(1):e84131.
[15] PIETRUKANIEC M,MIGACZ M,AK-GOB A,et al.Could KIM-1 and NGAL levels predict acute kidney injury after paracentesis? -preliminary study[J].Renal Failure,2020,42(1):853-859.
[16] HUANG Y,DON-WAUCHOPE A C.The clinical utility of kidney injury molecule 1 in the prediction,diagnosis and prognosis of acute kidney injury:a systematic review[J].Inflamm Allergy Drug Targets,2011,10(4):260-271.
[17] WAJDA J,DUMNICKA P,KOLBER W,et al.The marker of tubular injury,kidney injury molecule-1(KIM-1),in acute kidney injury complicating acute pancreatitis:a preliminary study[J].J Clin Med,2020,9(5):1463.
[18] LATOCH E,KONOCZUK K,TARANTA-JANUSZ K,et al.Urine NGAL and KIM-1:tubular injury markers in acute lymphoblastic leukemia survivors[J].Cancer Chem Pharmacol,2020,86(6):741-749.
[19] LUTHRA A,TYAGI A.[TIMP-2]*[IGFBP7] for predicting early AKI[J].Anaesthesia Critical Care Pain Medicine,2019,38(6):677.
[20] CHINDARKAR N S,CHAWLA L S,STRASESKI J A,et al.Reference intervals of urinary acute kidney injury(AKI) markers[IGFBP7][TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI[J].Clin Chimica Acta,2016,452:32-37.
[21] FAN W,ANKAWI G,ZHANG J,et al.Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice[J].Clin Chem Lab Med,2019,57(5):567-576.
[22] HEUNG M,ORTEGA L,CHAWLA L,et al.Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury[J].Nephrology Dialysis Transplantation,2016,31(10):1633-1640.
[23] WILFLINGSEDER J,SUNZENAUER J,TORONYI E,et al.Molecular pathogenesis of post-transplant acute kidney injury:assessment of whole-genome mRNA and miRNA profiles[J].PLoS One,2014,9(8):e104164.
[24] AVERDUNK L,FITZNER C,LEVKOVICH T,et al.Secretory leukocyte protease inhibitor(SLPI)-a novel predictive biomarker of acute kidney injury after cardiac surgery:a prospective observational study[J].J Clin Med,2019,8(11):1931.
[25] DOU Q,HAO F,SUN L,et al.CRE and SRE mediate LPA-induced CCN1 transcription in mouse aortic smooth muscle cells[J].Can J Physiol Pharmacol,2017,95(3):275-280.
[26] ZHAO L,LI C,GUAN C,et al.Serum response factor,a novel early diagnostic biomarker of acute kidney injury[J].Aging,2021,13(2):2885-2894.
[27] LI C,ZHAO L,WANG Y,et al.Cysteine-rich protein 61,a specific ultra-early biomarker in kidney ischemia/reperfusion injury[J].Nephrology(Carlton,Vic),2019,24(8):798-805.
[28] GUO B,LYU Q,SLIVANO O,et al.Serum response factor is essential for maintenance of podocyte structure and function[J].J Am Soc Nephrol,2018,29(2):416-422.
[29] 胡忠,王进,郑娟.AECOPD患者血清suPAR水平及其临床诊断价值研究[J].现代医学,2017,45(1):33-37.
[30] HAYEK S,LEAF D,SAMMAN TAHHAN A,et al.Soluble urokinase receptor and acute kidney injury[J].N Engl J Med,2020,382(5):416-426.
[31] MOSSANEN J,PRACHT J,JANSEN T,et al.Elevated soluble urokinase plasminogen activator receptor and proenkephalin serum levels predict the development of acute kidney injury after cardiac surgery[J].Int J Mol Sci,2017,18(8):1662.
[32] DAL MONTE M,CAMMALLERI M,PECCI V,et al.Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy[J].J Cell Mol Med,2019,23(2):1034-1049.
[33] AZAM T,SHADID H,BLAKELY P,et al.Soluble urokinase receptor(SuPAR) in COVID-19-related AKI[J].J Am Soc Nephrol,2020,31(11):2725-2735. |
